Abstract
Original language | English |
---|---|
Pages (from-to) | 2257-2273 |
Number of pages | 17 |
Journal | Molecular Therapy |
Volume | 30 |
Issue number | 6 |
Early online date | 2022 |
DOIs | |
Publication status | Published - 1 Jun 2022 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells. / Ottaviani, Lara; Juni, Rio P.; de Abreu, Ricardo C. et al.
In: Molecular Therapy, Vol. 30, No. 6, 01.06.2022, p. 2257-2273.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells
AU - Ottaviani, Lara
AU - Juni, Rio P.
AU - de Abreu, Ricardo C.
AU - Sansonetti, Marida
AU - Sampaio-Pinto, Vasco
AU - Halkein, Julie
AU - Hegenbarth, Jana C.
AU - Ring, Nadja
AU - Knoops, Kevin
AU - Kocken, Jordy M. M.
AU - Jesus, Carlos de
AU - Ernault, Auriane C.
AU - el Azzouzi, Hamid
AU - Rühle, Frank
AU - Olieslagers, Servé
AU - Fernandes, Hugo
AU - Ferreira, Lino
AU - Braga, Luca
AU - Stoll, Monika
AU - Nascimento, Diana S.
AU - de Windt, Leon J.
AU - da Costa Martins, Paula A.
N1 - Funding Information: L.J.d.W. acknowledges support from the Netherlands CardioVascular Research Initiative : the Dutch Heart Foundation , Dutch Federation of University Medical Centers , ZonMw , and the Royal Netherlands Academy of Sciences ( CVON2017-ARENA PRIME ). L.J.d.W. was also supported by ERC Consolidator Grant 311549 CALMIRS and VICI Award 918-156-47 from NWO . J.M.M.K. and P.A.d.C.M. were supported by the Dutch CardioVascular Alliance (DCVA) awarded to the Phaedra Consortium as well as the Impulse Grant 2018 awarded to the Phaedra IMPACT Consortium ( 2012-08 , 2014-11 ). L.O. and P.d.C.M. were supported by a Dutch Heart Foundation grant ( NHS2015T066 ). V.S.-P. and R.C.d.A. were supported by Foundation for Science and Technology of Portugal (FCT) grants ( SFRH/BD/111799/2015 and SFRH/BD/129317/2017 , respectively). D.N. was supported by a Foundation for Science and Technology of Portugal (FCT) grant ( POCI-01-0145-FEDER-030985 ). This work was also partially supported by the H2020 Twinning project RESETageing ( GA 952266 ). We are grateful to the Core Facility Genomics (CFG) of the Medical Faculty of the University of Münster, Germany, for performing RNA sequencing and helping with data analysis. Funding Information: L.J.d.W. acknowledges support from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centers, ZonMw, and the Royal Netherlands Academy of Sciences (CVON2017-ARENA PRIME). L.J.d.W. was also supported by ERC Consolidator Grant 311549 CALMIRS and VICI Award 918-156-47 from NWO. J.M.M.K. and P.A.d.C.M. were supported by the Dutch CardioVascular Alliance (DCVA) awarded to the Phaedra Consortium as well as the Impulse Grant 2018 awarded to the Phaedra IMPACT Consortium (2012-08, 2014-11). L.O. and P.d.C.M. were supported by a Dutch Heart Foundation grant (NHS2015T066). V.S.-P. and R.C.d.A. were supported by Foundation for Science and Technology of Portugal (FCT) grants (SFRH/BD/111799/2015 and SFRH/BD/129317/2017, respectively). D.N. was supported by a Foundation for Science and Technology of Portugal (FCT) grant (POCI-01-0145-FEDER-030985). This work was also partially supported by the H2020 Twinning project RESETageing (GA 952266). We are grateful to the Core Facility Genomics (CFG) of the Medical Faculty of the University of Münster, Germany, for performing RNA sequencing and helping with data analysis. L.O. R.P.J. D.S.N. R.C.d.A. and P.A.d.C.M. conceived and planned the experiments. L.O. R.P.J. M.S. J.H. R.C.d.A. H.e.A. C.d.J. and D.S.N. carried out the experiments. V.S.-P. A.C.E. J.M.M.K. H.F. and S.O. contributed to sample preparation and analysis. L.O. R.P.J. V.S.-P. L.F. D.S.N. L.J.d.W. and P.A.d.C.M. contributed to the interpretation of the results. K.K. contributed to imaging acquisition and the respective data analysis. F.R. J.C.H. and M.S. contributed to the RNA sequencing data and respective analysis. J.C.H. contributed to RNA sequencing data analysis and visualization. L.O. R.P.J. and P.A.d.C.M. wrote the manuscript. P.A.d.C.M. supervised the execution and development of the project. All authors provided critical feedback and helped shape the research, analysis, and manuscript. L.J.d.W. and P.A.d.C.M. are cofounders of Mirabilis Therapeutics. Publisher Copyright: © 2022 The American Society of Gene and Cell Therapy
PY - 2022/6/1
Y1 - 2022/6/1
N2 - As mediators of intercellular communication, extracellular vesicles containing molecular cargo, such as microRNAs, are secreted by cells and taken up by recipient cells to influence their cellular phenotype and function. Here we report that cardiac stress-induced differential microRNA content, with miR-200c-3p being one of the most enriched, in cardiomyocyte-derived extracellular vesicles mediates functional cross-talk with endothelial cells. Silencing of miR-200c-3p in mice subjected to chronic increased cardiac pressure overload resulted in attenuated hypertrophy, smaller fibrotic areas, higher capillary density, and preserved cardiac ejection fraction. We were able to maximally rescue microvascular and cardiac function with very low doses of antagomir, which specifically silences miR-200c-3p expression in non-myocyte cells. Our results reveal vesicle transfer of miR-200c-3p from cardiomyocytes to cardiac endothelial cells, underlining the importance of cardiac intercellular communication in the pathophysiology of heart failure.
AB - As mediators of intercellular communication, extracellular vesicles containing molecular cargo, such as microRNAs, are secreted by cells and taken up by recipient cells to influence their cellular phenotype and function. Here we report that cardiac stress-induced differential microRNA content, with miR-200c-3p being one of the most enriched, in cardiomyocyte-derived extracellular vesicles mediates functional cross-talk with endothelial cells. Silencing of miR-200c-3p in mice subjected to chronic increased cardiac pressure overload resulted in attenuated hypertrophy, smaller fibrotic areas, higher capillary density, and preserved cardiac ejection fraction. We were able to maximally rescue microvascular and cardiac function with very low doses of antagomir, which specifically silences miR-200c-3p expression in non-myocyte cells. Our results reveal vesicle transfer of miR-200c-3p from cardiomyocytes to cardiac endothelial cells, underlining the importance of cardiac intercellular communication in the pathophysiology of heart failure.
KW - cardiac angiogenesis
KW - cardiac remodeling
KW - extracellular vesicles
KW - intercellular communication
KW - microRNAs
UR - http://www.scopus.com/inward/record.url?scp=85126926744&partnerID=8YFLogxK
U2 - 10.1016/j.ymthe.2022.03.002
DO - 10.1016/j.ymthe.2022.03.002
M3 - Article
C2 - 35278675
SN - 1525-0016
VL - 30
SP - 2257
EP - 2273
JO - Molecular Therapy
JF - Molecular Therapy
IS - 6
ER -